Volume | 644,436 |
|
|||||
News | - | ||||||
Day High | 31.71 | Low High |
|||||
Day Low | 30.77 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Twist Bioscience Corporation | TWST | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
31.07 | 30.77 | 31.71 | 31.54 | 31.08 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12,300 | 644,436 | $ 31.33 | $ 20,189,205 | - | 11.46 - 43.21 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:09:18 | 5 | $ 31.45 | USD |
Twist Bioscience (TWST) Options Flow Summary
Twist Bioscience Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.82B | 57.82M | - | 251.02M | -204.62M | -3.54 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Twist Bioscience News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TWST Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 28.39 | 32.09 | 27.41 | 30.22 | 1,145,593 | 3.15 | 11.10% |
1 Month | 34.21 | 34.50 | 27.41 | 31.00 | 871,517 | -2.67 | -7.80% |
3 Months | 38.00 | 43.21 | 27.41 | 35.36 | 886,253 | -6.46 | -17.00% |
6 Months | 15.59 | 43.21 | 14.42 | 31.35 | 1,084,449 | 15.95 | 102.31% |
1 Year | 12.85 | 43.21 | 11.46 | 24.74 | 1,113,153 | 18.69 | 145.45% |
3 Years | 135.11 | 144.14 | 11.46 | 39.77 | 984,692 | -103.57 | -76.66% |
5 Years | 33.07 | 214.07 | 11.46 | 50.15 | 805,696 | -1.53 | -4.63% |
Twist Bioscience Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States. |